Skip to Main Content


Skip Nav Destination

Abstract LB127: Prospective preclinical modeling to estimate clinical pharmacokinetics and doses of BDTX-189, an inhibitor of allosteric ErbB mutations in advanced solid malignancies

Cancer Res (2021) 81 (13_Supplement): LB127.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal